TLR4/NF-κB signaling pathway-mediated and oxLDL-induced up-regulation of LOX-1, MCP-1, and VCAM-1 expressions in human umbilical vein endothelial cells

Genetics and Molecular Research

Volumn 13, Issue 1, 2014, Pages 680-695

  Feng, Y ^a   Cai, Z R ^b   Tang, Y ^c   Hu, G ^c   Lu, J ^c   He, D ^c   Wang, S ^c  

^a THE FIRST AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Lectin like oxidized LDL receptor 1; Monocyte chemotactic protein 1; NF B; Oxidized low density lipoprotein (LDL); Toll like receptor 4; Vascular cell adhesion molecule 1

Indexed keywords

CELL ADHESION; CHEMOKINE CCL2; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; NF-KAPPA B; SCAVENGER RECEPTORS, CLASS E; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84893934916     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.January.28.13     Document Type: Article

References (23)

1. An H, Qian C and Cao X (2010). Regulation of Toll-like receptor signaling in the innate immunity. Sci. China Life Sci. 53: 34-43.
2. Baeuerle PA (1991). The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim. Biophys. Acta 1072: 63-80.
3. Chavez-Sanchez L, Madrid-Miller A, Chavez-Rueda K, Legorreta-Haquet MV, et al. (2010). Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response. Hum. Immunol. 71: 737-744.
4. Edfeldt K, Swedenborg J, Hansson GK and Yan ZQ (2002). Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105: 1158-1161.
5. Fisker Hag AM, Pedersen SF and Kjaer A (2008). Gene expression of LOX-1, VCAM-1, and ICAM-1 in pre-atherosclerotic mice. Biochem. Biophys. Res. Commun. 377: 689-693.
6. Geng H, Wang A, Rong G, Zhu B, et al. (2010). The effects of ox-LDL in human atherosclerosis may be mediated in part via the Toll-like receptor 4 pathway. Mol. Cell Biochem. 342: 201-206.
7. Hacker H, Redecke V, Blagoev B, Kratchmarova I, et al. (2006). Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439: 204-207.
8. Hajishengallis G, Wang M, Bagby GJ and Nelson S (2008). Importance of TLR2 in early innate immune response to acute pulmonary infection with Porphyromonas gingivalis in mice. J. Immunol. 181: 4141-4149.
9. Hayden MS and Ghosh S (2008). Shared principles in NF-kappaB signaling. Cell 132: 344-362.
10. Li D and Mehta JL (2000). Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 101: 2889-2895.
11. Li T, Hu J, Thomas JA and Li L (2005). Differential induction of apoptosis by LPS and taxol in monocytic cells. Mol. Immunol. 42: 1049-1055.
12. Michelsen KS, Wong MH, Shah PK, Zhang W, et al. (2004). Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. U. S. A. 101: 10679-10684.
13. Miller YI, Viriyakosol S, Worrall DS, Boullier A, et al. (2005). Toll-like receptor 4-dependent and-independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler. Thromb. Vasc. Biol. 25: 1213-1219.
14. Moriwaki H, Kume N, Sawamura T, Aoyama T, et al. (1998). Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 18: 1541-1547.
15. Nagase M, Hirose S, Sawamura T, Masaki T, et al. (1997). Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats. Biochem Biophys. Res. Commun. 237: 496-498.
16. Nagase M, Abe J, Takahashi K, Ando J, et al. (1998). Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene. J. Biol. Chem. 273: 33702-33707.
17. Pasini AF, Anselmi M, Garbin U, Franchi E, et al. (2007). Enhanced levels of oxidized low-density lipoprotein prime monocytes to cytokine overproduction via upregulation of CD14 and Toll-like receptor 4 in unstable angina. Arterioscler. Thromb. Vasc. Biol. 27: 1991-1997.
18. Simionescu M (2007). Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler. Thromb. Vasc. Biol. 27: 266-274.
19. Sivapalaratnam S, Farrugia R, Nieuwdorp M, Langford CF, et al. (2011). Identification of candidate genes linking systemic inflammation to atherosclerosis; results of a human in vivo LPS infusion study. BMC Med. Genomics 4: 64.
20. Tew JG, El Shikh ME, El Sayed RM and Schenkein HA (2012). Dendritic cells, antibodies reactive with oxLDL, and inflammation. J. Dent. Res. 91: 8-16.
21. Yang JM, Wang Y, Qi LH, Wang Y, et al. (2011). Combinatorial interference of Toll-like receptor 2 and 4 synergistically stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice. J. Cell Mol. Med. 15: 602-611.
22. Zeibig S, Li Z, Wagner S, Holthoff HP, et al. (2011). Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis. Circ. Res. 108: 695-703.
23. Zhang M, Zhou SH, Li XP, Shen XQ, et al. (2008). Atorvastatin downregulates BMP-2 expression induced by oxidized low-density lipoprotein in human umbilical vein endothelial cells. Circ. J. 72: 807-812.